![Anticoagulation Associated With Improved Outcomes in Hospitalized COVID-19 Patients](http://res.cloudinary.com/broadcastmed/image/fetch/ar_16:9,c_fill,g_auto,f_auto,q_auto,w_1300/https%3A%2F%2F55933-bcmed.s3.amazonaws.com%2Fbcp%2Fimages%2FdmImage%2FSourceImage%2Fadobestock_3484840432.jpeg)
Anticoagulation Associated With Improved Outcomes in Hospitalized COVID-19 Patients
Systemic anticoagulation may be associated with improved outcomes among patients hospitalized with COVID-19, according to a research letter published May 6, 2020, in the Journal of the American College of Cardiology. Researchers analyzed the association between in-hospital anticoagulation administration and mortality among 2,773 patients hospitalized with COVID-19.